COR - Cencora - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03073E1055

Pharmaceuticals, Vaccines, Diagnostics, Healthcare Products, Blood Products

Cencora, Inc. is a leading pharmaceutical sourcing and distribution company that plays a vital role in the healthcare industry. Through its U.S. Healthcare Solutions segment, the company distributes a wide range of pharmaceutical products, over-the-counter healthcare items, home healthcare supplies, and equipment to various customers, including acute care hospitals, health systems, retail pharmacies, mail order pharmacies, and medical clinics.

In addition to its distribution services, Cencora provides a range of value-added services, including pharmacy management, staffing, and consulting services. The company also offers supply management software to retail and institutional healthcare providers, as well as packaging solutions to various healthcare providers. Furthermore, Cencora provides clinical trial support, product post-approval, and commercialization support services to biotechnology and pharmaceutical manufacturers.

The company's U.S. Healthcare Solutions segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products to healthcare providers, including physicians who specialize in various disease states, such as oncology. Moreover, Cencora provides data analytics, outcomes research, and additional services to biotechnology and pharmaceutical manufacturers, as well as sales force services to manufacturers.

In the animal health market, Cencora distributes pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related services, as well as global commercialization services. Cencora distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe.

Additionally, the company provides specialty transportation and logistics services for the biopharmaceutical industry. With its headquarters in Conshohocken, Pennsylvania, Cencora, Inc. was formerly known as AmerisourceBergen Corporation and changed its name in August 2023. The company was incorporated in 2001 and can be found online at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for COR - Cencora  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for COR - Cencora  - Stock Price & Dividends

COR Stock Overview

Market Cap in USD 38,516m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1995-04-04

COR Stock Ratings

Growth 5y 91.5
Fundamental 44.4
Dividend 40.92
Rel. Performance vs Sector -0.39
Analysts 4.11/5
Fair Price Momentum 238.81 USD
Fair Price DCF 277.17 USD

COR Dividends

Dividend Yield 12m 0.91%
Yield on Cost 5y 2.40%
Dividends CAGR 5y 4.20%
Payout Consistency 96.4%

COR Growth Ratios

Growth 12m 17.41%
Growth Correlation 12m 64%
Growth Correlation 3m -18%
CAGR 5y 21.51%
CAGR/Mean DD 5y 4.18
Sharpe Ratio 12m 0.74
Alpha vs SP500 12m -0.82
Beta vs SP500 5y weekly 0.61
ValueRay RSI 16.61
Volatility GJR Garch 1y 17.79%
Price / SMA 50 -1.76%
Price / SMA 200 2.31%
Current Volume 791.1k
Average Volume 20d 1535.9k

External Links for COR Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of COR stocks?
As of July 14, 2024, the stock is trading at USD 222.60 with a total of 791,079 shares traded.
Over the past week, the price has changed by -0.04%, over one month by -3.28%, over three months by -4.65% and over the past year by +16.97%.
What are the forecast for COR stock price target?
According to ValueRays Forecast Model, COR Cencora will be worth about 261.8 in July 2025. The stock is currently trading at 222.60. This means that the stock has a potential upside of +17.61%.
Issuer Forecast Upside
Wallstreet Target Price 212.3 -4.65
Analysts Target Price 209.7 -5.80
ValueRay Target Price 261.8 17.6